Latest News
Microsoft Prices Anniversary Xbox at $899.99 to Test Demand as Hardware Sales Slide
Microsoft's $899.99 Xbox Series X25 anniversary console hits preorders Thursday, a 12.5% premium over the standard model, as hardware revenue falls 29% in fiscal 2026.
Celularity Stock Surges 120% on MuseCell's $300M Manufacturing Deal
Celularity shares more than doubled after MuseCell outlined a potential $300 million manufacturing relationship, though the estimate is non-binding and filings are overdue.
Synopsys Soars 10.7% as AI-Driven Demand Boosts Outlook
Synopsys shares surged 10.7% after reporting strong Q3 results and raising its full-year outlook, driven by AI-fueled chip design demand.
Strategy Stock Soars 12% as Bitcoin Breaks $80K, Outpacing Crypto Fourfold
Strategy shares jumped 12% to $137.95 as Bitcoin topped $80,000, with MSTR outpacing the crypto by 4x. Bitcoin holdings now worth $67.5 billion.
Propanc Biopharma Rockets 151% on Promising PRP Pancreatic Cancer Data
Propanc Biopharma (PPCB) shares jumped 151% after PRP reduced tumor growth by over 90% in pancreatic cancer models, with volume nearly 20 times normal.
Wendy's Shares Tumble 13% as Trian Abandons Take-Private Plans
Wendy's shares dropped 13% after top shareholder Trian Fund Management said it won't pursue a take-private deal, erasing the takeover premium.
Hormel Stock Plunges 9% on Retail Volume Drop, Sales Forecast Cut
Hormel (HRL) shares dropped 9% after retail volume fell 9% and the company cut its full-year sales outlook. Foodservice gains failed to offset the weakness.
Callaway Stock Slips as Retailers Pull Good Good Gear Amid Ad Controversy
Callaway shares dropped 1.3% as major retailers pulled Good Good products after a controversial driver ad. Despite the setback, Q2 golf equipment sales rose 4.5%.
ServiceNow Jumps 9% as Salesforce AI Results Boost Software Sector
ServiceNow shares soared 9% after Salesforce's AI-driven results boosted software sector optimism, adding $11.7B to its market value.
Best Buy Stock Slips 5% Despite Strong Q2 and Raised Guidance
Best Buy shares dropped 5.4% despite beating Q2 estimates and raising guidance. A $34M tariff refund drove most of the margin gain, but valuation concerns persist.
Moderna Drops 5% on $2B Convertible Debt Sale
Moderna shares slid 5% after the company unveiled a $2B convertible notes offering, erasing $3B from its market cap. The financing follows a recent surge in its cancer-vaccine prospects.
Biohaven Shares Slide 7% as Investors Reassess Opakalim Deal Value
Biohaven shares fell 7.1% to $15.75, reversing nearly half of Wednesday's gains from its $400 million opakalim licensing agreement with SK Biopharmaceuticals.